Post by Andreas Konieczny
VP and Medical Director Oncology Europe
This is a remarkable milestone for platinum resistant ovarian cancer. I am very proud to be part of this journey bringing a highly innovative treatment option to European patients.
VP and Medical Director Oncology Europe
This is a remarkable milestone for platinum resistant ovarian cancer. I am very proud to be part of this journey bringing a highly innovative treatment option to European patients.